Back
Plus Therapeutics Stock Price Chart
Sponsored
PSTV
Sponsored
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
35
PSTV
Plus Therapeutics
Last Price:
1.29
Seasonality Move:
1.66%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PSTV is experiencing slight selling pressure.
Plus Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.31 | Sell |
20-day SMA: | 1.34 | Sell |
50-day SMA: | 1.4 | Sell |
200-day SMA: | 1.73 | Sell |
8-day EMA: | 1.3 | Buy |
20-day EMA: | 1.33 | Sell |
50-day EMA: | 1.4 | Sell |
200-day EMA: | 1.77 | Sell |
Plus Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 46.56 | Sell |
Chaikin Money Flow: | -37669 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.29 - 1.41) | Sell |
Bollinger Bands (100): | (1.33 - 1.67) | Sell |
Plus Therapeutics Technical Analysis
Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Plus Therapeutics Stock
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.31 while PSTV 8-day simple moving average is 1.31, which is a Sell signal.
- The stock price of PSTV is 1.31 while Plus Therapeutics 20-day SMA is 1.34, which makes it a Sell.
- Plus Therapeutics 50-day simple moving average is 1.40 while PSTV share price is 1.31, making it a Sell technically.
- PSTV stock price is 1.31 and Plus Therapeutics 200-day simple moving average is 1.73, creating a Sell signal.
PSTV Technical Analysis vs Fundamental Analysis
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.31. The Score for PSTV is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Plus Therapeutics Stock Info
Market Cap:
7.72M
Price in USD:
1.31
Share Volume:
128.08K
Plus Therapeutics 52-Week Range
52-Week High:
2.78
52-Week Low:
1.15
Sell
35
Plus Therapeutics (PSTV)
is a Sell
Plus Therapeutics Share Price Forecast
-
What is the Plus Therapeutics stock price today?
The Plus Therapeutics stock price is 1.31 USD today. -
Will PSTV stock go up or go down?
Plus Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Plus Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Plus Therapeutics is overvalued.
Is Plus Therapeutics Stock a Buy?
- Plus Therapeutics share price is 1.31 while PSTV 8-day exponential moving average is 1.30, which is a Buy signal.
- The stock price of PSTV is 1.31 while Plus Therapeutics 20-day EMA is 1.33, which makes it a Sell.
- Plus Therapeutics 50-day exponential moving average is 1.40 while PSTV share price is 1.31, making it a Sell technically.
- PSTV stock price is 1.31 and Plus Therapeutics 200-day simple moving average is 1.77, creating a Sell signal.
Fundamental Analysis of Plus Therapeutics
Is Plus Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.64 per share, and an increase next year of $0.17 per share.
Technical Analysis of Plus Therapeutics
Should I short Plus Therapeutics stock?
- PSTV Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Plus Therapeutics is a Sell
- Plus Therapeutics Relative Strength Index (RSI) is 46.56, which suggest Plus Therapeutics is oversold
- The Bollinger Bands (25) for Plus Therapeutics is (1.29 - 1.41), which suggest Plus Therapeutics is a Sell
- The Bollinger Bands (100) for Plus Therapeutics is (1.33 - 1.67), which suggest Plus Therapeutics is a Sell
* Plus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.